Coronavirus: Hungary To Produce Favipiravir Drug Within Months

  • 13 May 2020 11:23 AM
  • Hungary Matters
Coronavirus: Hungary To Produce Favipiravir Drug Within Months
Hungarian researchers have concluded the first phase of developing favipiravir, a medication proven effective against cases of the novel coronavirus in Asia.

Production of the drug might start as early as this autumn, the innovation and technology ministry said.

The infrastructure for clinical tests and manufacturing will be provided by a wide-ranging cooperation between the government, research institutes, universities and companies, the ministry said.

The government is funding the work with a 370 million forint (EUR 1.1m) grant, State Secretary Tamás Schanda said.

Favipiravir is used to alleviate flu symptoms. Clinical tests are yet to be conducted, and so it is not registered as a medicine in Europe and the US.

Favipiravir has shown results in patients with Covid-19, the ministry said.

Related links

Japan To Provide Coronavirus Medicine, Says Hungarian FM Szijjártó

  • How does this content make you feel?

XpatLoop Media Partner

Hungary Matters

Launched in January 2014, this newsletter published on week days covers 'everything you need to know about what’s going on in Hungary and beyond', according to its publisher the state media agency MTI.

Explore More Reports

  • Clocks To Go Back In Hungary On 29 October

    Clocks To Go Back In Hungary On 29 October

    • 25 Oct 2023 4:35 PM

    The clocks change twice a year for all residents of the European Countries, by one hour each time, once going backwards and once going forwards. In Europe the clocks go Back on the last Sunday in October every year, this time on Sunday 29 October.

  • 47 New Cases of Covid in Hungary, 2 Fatalities

    47 New Cases of Covid in Hungary, 2 Fatalities

    • 22 Jun 2023 10:51 AM

    Fully 47 new Covid-19 infections were confirmed last week, while two fatalities were registered in connection with the virus, the Coronavirus Press Centre said on Wednesday.